Interview: Tom Rönnlund, General Manager Nordic & Baltic Region, IMS Health
21.08.2013
Related Interviews
Jan van de Winkel – President & CEO, Genmab
Speaking exclusively to PharmaBoardroom, Jan van de Winkel highlights the tremendous progress that European biotech success story Genmab has made over the past six years, how its partnership model is…
Exclusive / GN Hearing CEO Gitte Aabo on Battling Hearing Aid Stigma & Digital Innovation
GN Hearing CEO Gitte Aabo highlights the significant unmet needs of hearing impairment patients, the role of private companies like GN in fighting against stigmas surrounding hearing aids, the digital…
Lars Georg Rust – Regional Managing Director North, Olympus
Lars Georg Rust outlines Olympus’ transition into fully-fledged MedTech company, the relevance of the Nordics and Netherlands to the global group, and some areas for improvement within the Danish hospital…
Biosimilars / Sandoz CEO Richard Saynor on Five Crucial Market Trends
In conversation at the FT’s Global Pharmaceutical & Biotechnology Conference last month, Sandoz CEO Richard Saynor outlined the current status of the biosimilars industry, the differences between the European and…
Saudi Arabia / Three Key Industry Trends to Watch
Looking to diversify its economy while simultaneously improving its healthcare system, Saudi Arabia has been rolling out incentives for international companies to invest in local manufacturing. Here are three trends…
US Generics & Biosimilars / Five Takeaways from Access! 2021
Dan Leonard of the Association for Accessible Medicines (AAM) highlights five key takeaways from the organisation’s remote but dynamic annual conference, and how the US generics and biosimilars industry might…
Latest Report
